| Name | Title | Contact Details |
|---|
Aulisa Medical USA, Inc., located in Palo Alto, integrates medical device science and information communication technologies to provide smart medical solutions for the evolving patient care landscape. The company specializes in wireless, wearable, FDA-cleared vital-signs measuring devices with continuous, cloud-based, patient monitoring and alarm systems. Through the development of new products, Aulisa continues to focus on growing the application of Digital Health, collecting large amounts of patient data for big data analytics and Artificial Intelligence (AI) to medical applications. The company is a subsidiary of Taiwan Aulisa Medical Devices Technologies, Inc., headquartered in Taipei, Taiwan, where a Research & Development center and operational headquarters was established in 2013.
Integer Holdings Corporation (NYSE:ITGR) is a leader in advanced medical device outsourcing (MDO) and serves its customers by providing comprehensive end-to-end solutions with its unparalleled expertise in innovation and manufacturing. Integer`s vision is to enhance the lives of patients worldwide by being its customer`s partner of choice for innovative medical technologies and services. Additionally, through Electrochem, an Integer company, it develops custom batteries for high-end niche applications in energy, military, and environment markets. The company`s medical device manufacturing brands include Greatbatch™ Medical and Lake Region Medical™.
Mental Health Corporation of Denver is a Denver, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Amico Corporation is a Richmond Hill, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Modulim is a pioneer in optical imaging solutions powered by spatial frequency domain imaging (SFDI) for noninvasive tissue and vascular assessment. Powered by SFDI, our Clarifi® Imaging System helps clinicians identify patients at-risk of complications due to microvascular dysfunction. The #ClarifiImagingSystem quantifies and maps five biomarkers of microvascular tissue oxygenation and perfusion. As a result, clinicians can quickly identify at-risk patients for earlier and more timely intervention so they may prevent complications such as diabetic foot ulcers and amputations. With its widespread adoption, our technology solutions have the potential to save limbs and lives, improve outcomes and reduce costs across the continuum of care by enabling early detection and intervention. Clarifi is affordable and easily integrated into a clinician`s practice. Clarifi imaging is supported by reimbursement (Current Procedural Terminology (CPT®) Proprietary Laboratory Analyses (PLA) code (0061U). Our proprietary technology - SFDI - was invented by Modulim`s founder and CTO David Cuccia, Ph.D., and his colleagues at UC Irvine`s Beckman Laser Institute. SFDI is a noninvasive tissue oxygen saturation technology that combines structured illumination with multiple wavelengths of light (visible and near-infrared) to allow for deeper and layer-specific assessment of tissue oxygenation and hemoglobin. This unique technology deciphers the reflection, absorbance, and scattering of light in tissue. Both David and Amaan Mazhar, Ph.D., Modulim`s VP of Research & Development, are both internationally-recognized experts in the field of medical photonics. #seebeyond